InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and cancer are increasingly in need of novel treatments that provide patients with better treatment alternatives and help to curb soaring healthcare costs. The company is in the process of in-licensing early- and late-stage compounds that have the potential to unlock the complex hormonal relationship between metabolism, insulin resistance, and obesity.
|
|
|
|
|
1-10 employees
View all InteKrin employees
|
|
|
IT Services and IT Consulting
|
|
|
650-941-5501
|
|
|
Los Altos, California
|
|
|
2005
|
The decision makers in InteKrin are Uday Devanaboyina, etc. Click to Find InteKrin decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.